{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:46:02Z","timestamp":1776811562383,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13760-021-01662-w","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T21:02:24Z","timestamp":1617310944000},"page":"1039-1044","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Case series of COVID-19 in patients with myasthenia gravis: a single institution experience"],"prefix":"10.1007","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7053-5460","authenticated-orcid":false,"given":"Sven","family":"\u017dupani\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Peri\u0107 \u0160itum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Majdak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Karaka\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Ba\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Spori\u0161","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"1662_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/jmv.25707","volume":"92","author":"L Zhang","year":"2020","unstructured":"Zhang L, Liu Y (2020) Potential interventions for novel coronavirus in China: a systematic review. J Med Virol 92:479\u2013490. https:\/\/doi.org\/10.1002\/jmv.25707","journal-title":"J Med Virol"},{"key":"1662_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","volume":"87","author":"T Singhal","year":"2020","unstructured":"Singhal T (2020) A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 87:281\u2013286. https:\/\/doi.org\/10.1007\/s12098-020-03263-6","journal-title":"Indian J Pediatr"},{"key":"1662_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","volume":"91","author":"A H\u00fcbers","year":"2020","unstructured":"H\u00fcbers A, Lascano AM, Lalive PH (2020) Management of patients with generalised myasthenia gravis and COVID-19: four case reports. J Neurol Neurosurg Psychiatry 91:1124\u20131125. https:\/\/doi.org\/10.1136\/jnnp-2020-323565","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1662_CR4","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE, Silva AMS, Estephan EP, Zambon AA, Mendon\u00e7a RH, Souza PVS, Pinto WBVR, Oliveira ASB, Dangoni-Filho I, Pouza AFP, Valerio BCO, Zanoteli E (2020) Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol 11:1053. https:\/\/doi.org\/10.3389\/fneur.2020.01053","journal-title":"Front Neurol"},{"key":"1662_CR5","doi-asserted-by":"publisher","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","volume":"412","author":"S Jacob","year":"2020","unstructured":"Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, Howard JF, Illa I, Mantegazza R, Murai H, Utsugisawa K, Vissing J, Wiendl H, Nowak RJ (2020) Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 412:116803. https:\/\/doi.org\/10.1016\/j.jns.2020.116803","journal-title":"J Neurol Sci"},{"key":"1662_CR6","doi-asserted-by":"publisher","first-page":"E65","DOI":"10.1002\/mus.27020","volume":"62","author":"H Kushlaf","year":"2020","unstructured":"Kushlaf H (2020) COVID -19 in muscle-specific kinase myasthenia gravis: a case report. Muscle Nerve 62:E65\u2013E66. https:\/\/doi.org\/10.1002\/mus.27020","journal-title":"Muscle Nerve"},{"key":"1662_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","volume":"173","author":"DA Restivo","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R (2020) Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med 173:1027\u20131028. https:\/\/doi.org\/10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"1662_CR8","doi-asserted-by":"publisher","first-page":"8845844","DOI":"10.1155\/2020\/8845844","volume":"2020","author":"E Aksoy","year":"2020","unstructured":"Aksoy E, Oztutgan T (2020) COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature. Case Rep Infect Dis 2020:8845844. https:\/\/doi.org\/10.1155\/2020\/8845844","journal-title":"Case Rep Infect Dis"},{"key":"1662_CR9","doi-asserted-by":"publisher","first-page":"117053","DOI":"10.1016\/j.jns.2020.117053","volume":"417","author":"N Rein","year":"2020","unstructured":"Rein N, Haham N, Orenbuch-Harroch E, Romain M, Argov Z, Vaknin-Dembinsky A, Gotkine M (2020) Description of 3 patients with myasthenia gravis and COVID-19. J Neurol Sci 417:117053. https:\/\/doi.org\/10.1016\/j.jns.2020.117053","journal-title":"J Neurol Sci"},{"key":"1662_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/mus.26918","volume":"62","author":"P Anand","year":"2020","unstructured":"Anand P, Slama MCC, Kaku M, Ong C, Cervantes-Arslanian AM, Zhou L, David WS, Guidon AC (2020) COVID -19 in patients with myasthenia gravis. Muscle Nerve 62:254\u2013258. https:\/\/doi.org\/10.1002\/mus.26918","journal-title":"Muscle Nerve"},{"key":"1662_CR11","doi-asserted-by":"publisher","first-page":"106045","DOI":"10.1016\/j.clineuro.2020.106045","volume":"196","author":"S Singh","year":"2020","unstructured":"Singh S, Govindarajan R (2020) COVID-19 and generalized myasthenia gravis exacerbation: a case report. Clin Neurol Neurosurg 196:106045. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106045","journal-title":"Clin Neurol Neurosurg"},{"key":"1662_CR12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5811\/cpcem.2020.9.49049","volume":"4","author":"P Moschella","year":"2020","unstructured":"Moschella P, Roth P (2020) Isolated COVID-19 Infection precipitates myasthenia gravis crisis: a case report. Clin Pract Cases Emerg Med 4:524\u2013526. https:\/\/doi.org\/10.5811\/cpcem.2020.9.49049","journal-title":"Clin Pract Cases Emerg Med"},{"key":"1662_CR13","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.msard.2020.102182","volume":"42","author":"C Valencia-Sanchez","year":"2020","unstructured":"Valencia-Sanchez C, Wingerchuk DM (2020) A fine balance: immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19. Mult Scler Relat Disord 42:102182. https:\/\/doi.org\/10.1016\/j.msard.2020.102182","journal-title":"Mult Scler Relat Disord"},{"key":"1662_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","volume":"24","author":"J van Paassen","year":"2020","unstructured":"van Paassen J, Vos JS, Hoekstra EM, Neumann KMI, Boot PC, Arbous SM (2020) Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care 24:696. https:\/\/doi.org\/10.1186\/s13054-020-03400-9","journal-title":"Crit Care"},{"key":"1662_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.thromres.2020.06.029","volume":"194","author":"MY Abou-Ismail","year":"2020","unstructured":"Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L (2020) The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res 194:101\u2013115. https:\/\/doi.org\/10.1016\/j.thromres.2020.06.029","journal-title":"Thromb Res"},{"key":"1662_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.mbc.0000172694.85233.a8","volume":"16","author":"D Paran","year":"2005","unstructured":"Paran D, Herishanu Y, Elkayam O, Shopin L, Ben-Ami R (2005) Venous and arterial thrombosis following administration of intravenous immunoglobulins. Blood Coagul Fibrinolysis 16:313\u2013318. https:\/\/doi.org\/10.1097\/01.mbc.0000172694.85233.a8","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1662_CR17","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","volume":"155","author":"I Marie","year":"2006","unstructured":"Marie I, Maurey G, Herv\u00e9 F, Hellot M-F, Levesque H (2006) Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol 155:714\u2013721. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07390.x","journal-title":"Br J Dermatol"},{"key":"1662_CR18","doi-asserted-by":"publisher","first-page":"100735","DOI":"10.1016\/j.jbior.2020.100735","volume":"77","author":"A Ribes","year":"2020","unstructured":"Ribes A, Vardon-Bounes F, M\u00e9mier V, Poette M, Au-Duong J, Garcia C, Minville V, Si\u00e9 P, Bura-Rivi\u00e8re A, Voisin S, Payrastre B (2020) Thromboembolic events and COVID-19. Adv Biol Regul 77:100735. https:\/\/doi.org\/10.1016\/j.jbior.2020.100735","journal-title":"Adv Biol Regul"},{"key":"1662_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jinf.2020.03.044","volume":"81","author":"Y Xie","year":"2020","unstructured":"Xie Y, Cao S, Dong H, Li Q, Chen E, Zhang W, Yang L, Fu S, Wang R (2020) Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19. J Infect 81:318\u2013356. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.044","journal-title":"J Infect"},{"key":"1662_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s40265-020-01367-z","volume":"80","author":"JG Rizk","year":"2020","unstructured":"Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN (2020) Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs 80:1267\u20131292. https:\/\/doi.org\/10.1007\/s40265-020-01367-z","journal-title":"Drugs"},{"key":"1662_CR21","doi-asserted-by":"publisher","first-page":"e0242651","DOI":"10.1371\/journal.pone.0242651","volume":"15","author":"CS King","year":"2020","unstructured":"King CS, Sahjwani D, Brown AW, Feroz S, Cameron P, Osborn E, Desai M, Djurkovic S, Kasarabada A, Hinerman R, Lantry J, Shlobin OA, Ahmad K, Khangoora V, Aryal S, Collins AC, Speir A, Nathan S (2020) Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS ONE 15:e0242651. https:\/\/doi.org\/10.1371\/journal.pone.0242651","journal-title":"PLoS ONE"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01662-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-021-01662-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-021-01662-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T22:11:49Z","timestamp":1628374309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-021-01662-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1662"],"URL":"https:\/\/doi.org\/10.1007\/s13760-021-01662-w","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"11 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All participants have consented to the submission of the case reports to the journal.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}